Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9).
about
Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing ProgramOutcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.The optimal use of PEG-asparaginase in relapsed ALL--lessons from the ALLR3 Clinical Trial.
P2860
Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of relapsed precurso ...... y Group) study 9411 (SIMAL 9).
@en
Treatment of relapsed precurso ...... th intensive chemotherapy: POG
@nl
type
label
Treatment of relapsed precurso ...... y Group) study 9411 (SIMAL 9).
@en
Treatment of relapsed precurso ...... th intensive chemotherapy: POG
@nl
prefLabel
Treatment of relapsed precurso ...... y Group) study 9411 (SIMAL 9).
@en
Treatment of relapsed precurso ...... th intensive chemotherapy: POG
@nl
P2093
P2860
P1476
Treatment of relapsed precurso ...... y Group) study 9411 (SIMAL 9).
@en
P2093
Alan Homans
Amy Billett
Bruce Camitta
Eric Sandler
George Buchanan
Mark L Bernstein
Meenakshi Devidas
Michael E Kelly
Thomas Abshire
Xiaomin Lu
P2860
P304
P356
10.1097/MPH.0B013E31829F3235
P577
2013-10-01T00:00:00Z